RB and Evolve BioSystems announce a partnership in the sale of Evivo®, Evolve BioSystems’ infant probiotic. The partnership leverages assets and expertise from both companies to drive scale in messaging directly to consumers and health […]
Da Volterra, a clinical-stage biopharmaceutical company developing innovative products to protect the intestinal microbiota, announced the results of DAV132- CL-1005, a Phase 1 clinical study which investigated the potential effect of DAV132 on the bioavailability […]
Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early treatment and management of cardio-metabolic diseases, is entering into a strategic collaboration with Nestlé Health Science (NHSc). The aim is to further […]
EnteroSatys® was named “Best Nutraceutical Product of the Year” at Food Matters Live Awards 2019. The awards ceremony took place on Tuesday 19 November at ExCeL London as a part of a broader event, now […]
4D pharma plc (AIM: DDDD), a clinical-stage pharmaceutical company leading the development of Live Biotherapeutics, today announced preliminary safety and clinical observations from an ongoing Phase I/II clinical trial, in collaboration with MSD, a tradename […]
Cognate BioServices (Cognate), a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products and Cobra Biologics (Cobra), a leading CDMO specialized in providing manufacturing services for plasmid DNA and […]
It’s become common for patients in the intensive care unit (ICU), both children and adults, to receive probiotics. Often, they are started at home to counteract diarrhea caused by antibiotics. There is also interest in […]
Laboratoires IPRAD and BIOCODEX have entered into exclusive negotiations on the acquisition of Laboratoires IPRAD by Biocodex. Biocodex and Laboratoires IPRAD have complementary product portfolios in the field of family health. The two companies together […]
Constipation is a common complaint in patients with Parkinson’s disease (PD). Fecal microbiome transplantation (FMT) and pre- and probiotics are potential options for treating constipation and restoring the microbiome of patients with Parkinson’s disease (PD), […]
Several doctors spoke before the FDA in Washington D.C. on November 4, advocating for C.diff treatment improvements. Among those in attendance were gastroenterologists Paul Feuerstadt (Yale), Colleen Kelly (Brown), Sahil Khanna (Mayo Clinic), Jessica Allegretti […]
Arranta Bio (“Arranta”) announced today the acquisition of Captozyme™, and with it the establishment of Arranta’s Center of Excellence for process and analytical development and early clinical supply for microbiome clients with the transfer of […]